Skip to main content
white paper intouch

The Aftermath: COVID-19 Insights & Recommendations

The COVID-19 emergency has changed many aspects of health care as we know it. This has prompted pharmaceutical commercial organizations to adapt quickly to the new normal and define a strategy for a radically different future.

Find out about best practices, opportunities and actions for the future in the white paper “The aftermath: Covid-19 insights & recommendations” produced Intouch Group and Digital Health Coalition.